Fluticasone Propionate for Hay Fever

HR
Overseen ByHaleon Response Center
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: HALEON
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This study is designed to visualize the response to use of fluticasone propionate nasal spray (Flonase Allergy Relief) to relieve facial allergy symptoms in individuals with moderate to severe seasonal allergic rhinitis (SAR).

Are You a Good Fit for This Trial?

This trial is for adults who have moderate to severe seasonal allergies affecting their nose (hay fever).

Inclusion Criteria

Participant must give signed and dated written informed consent prior to any study-related activities and comply with study procedures and protocol
Participant must sign and date the Participant Photo Release Form agreeing to use of photographs and images for promotional and/or marketing purposes by the Sponsor
Medical history of seasonal allergic rhinitis/rhinoconjunctivitis in the past two years
See 6 more

Exclusion Criteria

Participant deemed by investigator not suitable to participate
Past or present medical conditions judged by Investigator to affect study outcome
Employee of investigational site involved in study or immediate family member, or Haleon employee involved in study or immediate family member
See 26 more

What Are the Treatments Tested in This Trial?

Interventions

  • Fluticasone propionate

Trial Overview

The study tests how well fluticasone propionate nasal spray (Flonase Allergy Relief) works in relieving facial allergy symptoms in people with seasonal allergic rhinitis.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Test GroupExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

HALEON

Lead Sponsor

Trials
40
Recruited
6,000+